www.verygoodnewsisrael.blogspot.com
ISRAEL’S MEDICAL ACHIEVEMENTS
Human trials for X-ray surgical glasses. I reported previously (Oct 2017) on Xvision (previously VIZOR), the Augmented Reality surgical navigation system from Israel’s Augmedics. Following testing on cadavers, Xvision is now undergoing human trials and has been successfully tested in six spinal operations.
https://www.businesswire.com/news/home/20180808005218/en/Augmedics-Begins-First-in-Human-Clinical-Trial-xvision-spine-XVShttps://worldisraelnews.com/israeli-made-goggles-give-surgeons-x-ray-vision/
https://www.youtube.com/watch?v=6xDCiCT2nH4
The first wireless VAD. Doctors in Kazakhstan have implanted a wireless ventricular assist device (VAD) into a human for the first time. The VAD is made by Jarvik Heart Inc but the technology for charging the battery was developed by Israel-based Leviticus Cardio. Wireless VADs have less risk of infection than wired VADs.
https://unitedwithisrael.org/israeli-wireless-heart-pump-implanted-in-first-patient/
https://www.youtube.com/watch?v=A0JI_2cgccA
https://www.jhltonline.org/article/S1053-2498(19)31346-4/fulltext
Better connections for dialysis patients. 50% of dialysis patients experience failure of their AV fistula – the tubes that connect their arteries and veins to the dialysis machine. Israel’s Laminate Medical has developed the VasQ – a vascular support device that protects the connection. It takes only one extra minute to implant it.
https://www.calcalistech.com/ctech/articles/0,7340,L-3755441,00.html
https://www.youtube.com/watch?v=2W3HoTH2x58
Nano wound protection. Israel’s Nanomedic has developed the SpinCare device – a portable electrospinning wound care system that remotely generates a nano-fibrous protective layer on the skin for tissue healing. The wound is never touched, preventing infection and bandages can be changed without sticking to the wound.
http://nocamels.com/2019/02/groundbreaking-israeli-medical-device-treats-burns/
http://israelbetweenthelines.com/2019/02/14/easier-cure-for-burn-victims/
https://www.youtube.com/watch?v=rqKqTIgXZT8
Treatment for pulmonary hypertension. Israel’s Teva has launched ALYQ – a generic form of Adcirca, to reduce the symptoms of pulmonary arterial hypertension (PAH).
https://en.globes.co.il/en/article-teva-launches-generic-pulmonary-hypertension-drug-1001272239
Israeli cancer death rates drop. Between 1995 and 2016, cancer deaths for Israeli Jewish men dropped by an average of 1.7% every year and for Israeli Jewish women by 1.6%. Cancer deaths for Israeli Arabs also dropped significantly. Although Israel has the 50th highest cancer rate in the world, it is 92nd for cancer deaths.
https://www.timesofisrael.com/cancer-cases-drop-among-men-almost-double-among-arab-women/
Finding donors for complex kidney patients. Israel’s Beilinson Hospital has implemented a new program that locates matching donors for kidney transplant patients who suffer from high levels of antibodies due to previous transplants or blood donations. It has already helped the hospital perform successful transplants for 39 patients.
https://jewishnews.timesofisrael.com/programme-at-israeli-hospital-to-locate-kidney-transplant-donors/
Link between Celiac disease and Eating disorders. (TY Kay) Kay’s son-in-law Dr. Itay Tokatly-Latzer and his Tel Aviv University research team have linked adolescents and young adults with celiac disease (CD) to higher incidences of disordered eating behavior. Many CD patients exhibit excessive control over their food.
https://www.jpost.com/HEALTH-SCIENCE/Could-celiac-disorder-cause-disordered-eating-Israeli-researchers-find-a-link-579759
Health company’s $150 million fund. The Assuta chain of medical clinics and private hospitals, controlled by Israel’s Maccabi Health Services, has founded a venture capital fund for investing in medical devices in the later stages of development. It has already raised $35 million and plans to reach $150 million by mid-2019.
https://en.globes.co.il/en/article-assuta-to-raise-150m-vc-health-fund-1001269776